DeepMind Spinout Isomorphic Labs Raises Funds at $40B–$50B Valuation

Isomorphic Labs, a DeepMind spinout focused on AI drug discovery, is in funding talks that would value the company between $40 billion and $50 billion. The capital raise underscores investor appetite for artificial intelligence applications in life sciences and accelerates the commercialization of AI-driven therapeutic research.

The valuation reflects the premium markets place on early-stage AI companies addressing high-impact sectors such as pharmaceutical development and healthcare innovation.

#AI #biotech #venture